Memantine in moderate to severe Alzheimer’s disease

被引：2
|
作者：
Andrew Kertesz
机构：
来源：
Current Neurology and Neuroscience Reports | 2003年 / 3卷 / 6期
关键词：
NMDA; Memantine; MMSE Score; NMDA Antagonist; Global Deterioration Scale;
D O I：
10.1007/s11910-003-0051-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 486
页数：1
相关论文
共 50 条
  • [41] Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer’s Disease
    Anders Wimo
    Bengt Winblad
    Albrecht Stöffler
    Yvonne Wirth
    Hans-Jörg Möbius
    [J]. PharmacoEconomics, 2003, 21 : 327 - 340
  • [42] Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease
    Emre, Murat
    Mecocci, Patrizia
    Stender, Karina
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2008, 14 (02) : 193 - 199
  • [43] Specific benefits of memantine on behavioural symptoms in patients with moderate to severe Alzheimer's disease
    Cummings, J.
    Gauthier, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S528 - S529
  • [44] Memantine for moderate and severe Alzheimer's disease: systematic review and meta-analysis
    Minakaran, N.
    McShane, R.
    Sastre, A. Areosa
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 34 - 34
  • [45] Memantine - A pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease
    Plosker, GL
    Lyseng-Williamson, KA
    [J]. PHARMACOECONOMICS, 2005, 23 (02) : 193 - 206
  • [46] Specific benefits of memantine on behavioural symptoms in patients with moderate to severe Alzheimer's disease
    Gauthier, S.
    Cooper, J.
    Loft, H.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 65 - 65
  • [47] Memantine in moderate to severe Alzheimer’s disease: an observational post-marketing study
    Michael Rainer
    A. Wuschitz
    C. Jagsch
    C. Erb
    J.-J. Chirikdjian
    H. A. M. Mucke
    [J]. Journal of Neural Transmission , 2011, 118
  • [48] Memantine treatment is beneficial for functional capacities of patients with moderate to severe Alzheimer's disease
    Wirth, Y
    Doody, RS
    Schmitt, FA
    Möbius, HJ
    Stöffler, A
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S207
  • [49] Memantine and individual activities of daily living in moderate to severe Alzheimer's disease.
    Feldman, H
    Schmitt, F
    Doraiswamy, P
    Graham, SM
    Bell, JM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S26 - S26
  • [50] Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease
    Wimo, A
    Winblad, B
    Stoffler, A
    Wirth, Y
    Möbius, HJ
    [J]. PHARMACOECONOMICS, 2003, 21 (05) : 327 - 340
12345